본문 바로가기

Vesical Imaging-Reporting and Data System for Multiparametric MRI to Predict the Presence of Muscle Invasion for Bladder Cancer

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
JOURNAL OF MAGNETIC RESONANCE IMAGING52(4) · pp.1249 · 2020
피인용
Web of Science 37Scopus 37
FWCI (Scopus)
0
JCR IF
JCR 2019 3.954
ISSN
1053-1807

저자

  1. 홍승백제1저자Department of Radiology, Biomedical Research Institute, Pusan National University Hospital, and Pusan National University School of Medicine, Busan, Korea
  2. 이남경교신저자Department of Radiology, Biomedical Research Institute, Pusan National University Hospital, and Pusan National University School of Medicine, Busan, Korea
  3. 김석Department of Radiology, Biomedical Research Institute, Pusan National University Hospital, and Pusan National University School of Medicine, Busan, Korea
  4. 손일완Department of Radiology, Biomedical Research Institute, Pusan National University Hospital, and Pusan National University School of Medicine, Busan, Korea
  5. 하홍구Department of Urology, Biomedical Research Institute, Pusan National University Hospital, and Pusan National University School of Medicine, Busan, Korea
  6. 구자윤Department of Urology, Biomedical Research Institute, Pusan National University Hospital, and Pusan National University School of Medicine, Busan, Korea
  7. 김경환Department of Urology, Biomedical Research Institute, Pusan National University Hospital, and Pusan National University School of Medicine, Busan, Korea
  8. 박원영Department of Pathology, Biomedical Research Institute, Pusan National University Hospital, and Pusan National University School of Medicine, Busan, Korea

초록

Background The Vesical Imaging-Reporting and Data System (VI-RADS) is a newly developed system of bladder cancer staging with multiparametric MRI (mpMRI), which can be used to predict the presence of muscle invasion for bladder cancer. Purpose To evaluate the accuracy of three mpMRI series (T2WI, diffusion-weighted imaging [DWI], and dynamic contrast-enhanced image [DCEI]) and VI-RADS for diagnosing the muscle invasive bladder cancer (MIBC). Study Type Retrospective. Population In all, 66 pathologically proven bladder cancers in 32 patients. Field Strength/Sequence Before the diagnostic MRI with an intramuscular antispasmodic agent, optimal bladder distension was confirmed. 3.0T MRI with T2WI, DWI, and DCEI. Assessment Three reviewers independently assessed and scored the bladder cancers in T2WI, DWI, and DCEI using a five-point score system. Based on the scores in the three sequences, reviewers scored each bladder cancer with reference to VI-RADS categories. We evaluated the diagnostic performance of each of three mpMRI sequences and the final VI-RADS categorization for diagnosing MIBC. Statistical Tests Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and the area under the curve (AUC) of each of three sequences separately and VI-RADS categorization for diagnosing the MIBC. Results The diagnostic performances of each of the three mpMRI series and VI-RADS for diagnosing MIBC were excellent. Especially using the optimal cutoff score >3 for predicting MIBC on DWI, DCEI, and VI-RADS, the sensitivity, specificity, PPV, NPV, and AUC values were 90% (95% confidence interval [CI]: 0.56, 1.00), 100% (95% CI: 0.94, 1.00), 100% (95% CI: 0.66. 1.00), 98.3% (95% CI: 0.91, 1.00), and 0.95, respectively. Data Conclusion mpMRI based on VI-RADS can stratify patients with bladder cancer according to the presence of muscle invasion. Level of Evidence 3. Technical Efficacy Stage 2.

키워드

urinary bladdermagnetic resonance imagingneoplasmtumor stagingdiagnosis2ND TRANSURETHRAL RESECTIONTRANSITIONAL-CELL CARCINOMADIAGNOSTIC PERFORMANCEACCURACYSTAGE

식별자

Scopus EID
2-s2.0-85082963201
WoS UID
000521823900001